Similar clinical studies reported that decreased MEF-2C mRNA transcripts in leukocytes may serve as a diagnostic marker in Alzheimer's disease (AD), and this may also be associated with the decline in cognitive ability [205]. This evidence concerns the gene MEF2C and Alzheimer disease.